Dexcom shares plummet more than 30% after company lowers fiscal year guidance

Shares of Dexcom tumbled more than 33% in after-hours trading Thursday after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance.

Here’s how the company did:

• Earnings per share: 43 cents adjusted vs. 39 cents expected by LSEG
• Revenue: $1 billion vs. $1.04 billion expected by LSEG

Dexcom’s revenue increased 15% from $871.3 million a year earlier, according to a release.

This is breaking news. Please refresh for updates.